Citadel Advisors’s Otonomy, Inc. OTIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,100
Closed -$3K 15826
2022
Q3
$3K Sell
11,100
-22,600
-67% -$19.8K ﹤0.01% 12421
2022
Q2
$70K Sell
33,700
-36,900
-52% -$76.8K ﹤0.01% 11711
2022
Q1
$169K Buy
70,600
+18,400
+35% +$39.1K ﹤0.01% 11720
2021
Q4
$109K Sell
52,200
-14,100
-21% -$29K ﹤0.01% 12631
2021
Q3
$127K Buy
66,300
+1,800
+3% +$3.05K ﹤0.01% 12580
2021
Q2
$144K Sell
64,500
-171,400
-73% -$396K ﹤0.01% 12542
2021
Q1
$602K Buy
235,900
+204,300
+647% +$837K ﹤0.01% 9285
2020
Q4
$204K Buy
+31,600
New +$144K ﹤0.01% 9714
2018
Q1
Sell
-17,600
Closed -$98K 8967
2017
Q4
$98K Buy
17,600
+5,400
+44% +$23.4K ﹤0.01% 7447
2017
Q3
$40K Buy
+12,200
New +$164K ﹤0.01% 7232
2016
Q1
Sell
-300
Closed -$8K 8313
2015
Q4
$8K Buy
300
+200
+200% +$4.98K ﹤0.01% 8353
2015
Q3
$2K Sell
100
-300
-75% -$7.1K ﹤0.01% 8754
2015
Q2
$9K Buy
+400
New +$11.2K ﹤0.01% 8448

Other funds holding OTIC

Citadel Advisors's OTIC Position: Q3 2022 in Review

Citadel Advisors sold out of Otonomy, Inc. (OTIC) in Q3 2022, closing a stake of 36,160 shares — an estimated $31.7K sold.

Citadel Advisors first reported a position in OTIC in Q2 2015 and held it in 25 quarters. The position peaked at $7.81M in Q4 2020. 40 funds tracked by Wall St. Rank hold OTIC as of Q3 2022.

  • Citadel Advisors reported no remaining Otonomy, Inc. position as of Q3 2022 after selling out during the quarter.
  • Citadel Advisors sold 36,160 Otonomy, Inc. shares in Q3 2022, an estimated $31.7K.
  • Citadel Advisors first reported a position in Otonomy, Inc. in Q2 2015 and held it in 25 quarters.
  • Citadel Advisors's Otonomy, Inc. position peaked at $7.81M in Q4 2020.
  • 40 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q3 2022.

Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.